TransCode Therapeutics Inc (NASDAQ:RNAZ) traded at $0.74 at close of the session on current trade day and made an upward move of 6.02% on its previous day’s price.
Looking at the stock we see that its previous close was $0.70 and the beta (5Y monthly) reads 0.631 with the day’s price range being $0.6701 – $0.78. In terms of its 52-week price range, RNAZ has a high of $21.20 and a low of $0.22. The company’s stock has gained about 183.79% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
TransCode Therapeutics Inc has a market cap of $12.76 million and is expected to release its quarterly earnings report in November. Estimates by analysts give the company expected earnings per share (EPS) of -0.49, with the EPS growth for the year raised at -2.06 for current year and -2.06 for next year.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 300k, with a low of 300k and a high of 300k.
On the other hand, looking at the outlook for the RNAZ stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 35.66% off its SMA20 and 96.69% from its 50-day simple moving average. The RSI (14) is pointing at 66.15 while the volatility over the past week is 22.35% and jumps to 28.55% over the past one month. The beta value is 0.66, while the average true range (ATR) is currently pointing at 0.11.
Coming back to TransCode Therapeutics Inc (NASDAQ:RNAZ), we note that the average 3-month trading volume was 2.13 million, while that of the preceding 10-day period stands at 2.22 million. Current shares outstanding are 17.27 million.
The insiders hold 0.19% of the company’s shares while institutions hold 11.46%. The data shows that short shares as of 2024-09-30, stood at 1.38 million at a short ratio of 0.45. This represents a 801.00 short interest in shares outstanding on 2024-09-30. Shares short rose in September from the previous month at 0.28 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -88.79% down in year-to-date price movement.
